VeriSign VRSN Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.66B+6.4% | $1.56B+4.3% | $1.49B+4.8% | $1.42B+7.3% | ||
| $196.3M+2.6% | $191.4M-3.0% | $197.3M-1.7% | $200.7M+4.6% | ||
| $1.46B+6.9% | $1.37B+5.4% | $1.3B+5.8% | $1.22B+7.8% | ||
| 88.2%+0.4pp | 87.7%+0.9pp | 86.8%+0.9pp | 85.9%+0.4pp | ||
| $103.6M+7.1% | $96.7M+6.3% | $91M+6.2% | $85.7M+6.5% | ||
| $235.7M+11.7% | $211.1M+3.4% | $204.2M+4.5% | $195.4M+3.7% | ||
| $535.6M+7.3% | $499.2M+1.4% | $492.5M+2.2% | $481.8M— | ||
| $1.12B+5.9% | $1.06B+5.8% | $1B+6.1% | $943.1M+8.8% | ||
| 67.7%-0.3pp | 67.9%+0.9pp | 67%+0.8pp | 66.2%+0.9pp | ||
| $77M+2.3% | $75.3M0.0% | $75.3M0.0% | $75.3M-9.6% | ||
| $10.1M-15.8% | $12M-52.4% | $25.2M+180% | $9M— | ||
| $1.07B+4.6% | $1.02B+4.6% | $976.5M+10.9% | $880.2M+12.5% | ||
| $242.8M+2.8% | $236.2M+37.3% | $172M-16.7% | $206.4M+8,038% | ||
| $825.7M+5.1% | $785.7M-3.9% | $817.6M+21.3% | $673.8M-14.1% | ||
| 49.8%-0.6pp | 50.4%-4.3pp | 54.8%+7.5pp | 47.3%-11.8pp | ||
| $1.15B+5.2% | $1.1B+4.8% | $1.04B+5.5% | $990M+8.2% | ||
| 69.6%-0.8pp | 70.3%+0.3pp | 70%+0.5pp | 69.5%+0.6pp | ||
| $1.12B+5.9% | $1.06B+5.8% | $1B+6.1% | $943.1M+8.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is VeriSign's revenue?
- VeriSign (VRSN) generated $1.7B in revenue over the trailing twelve months, up 6.8% year over year.
- Is VeriSign profitable?
- VeriSign reported $840.9M in net income over the trailing twelve months, a 50.0% net margin.
- What are VeriSign's profit margins?
- Gross margin is 88.3% and operating margin is 67.9%, with a 50.0% net margin.
- What is VeriSign's earnings per share?
- VeriSign's diluted EPS over the trailing twelve months is $9.05.
- Where does VeriSign's income statement data come from?
- Every line is extracted from VeriSign's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
